Background and aims: Diabetes mellitus is the disease-challenge of our century, characterized by an increase in serum glycemia, which may lead to the occurrence of micro- and macro-vascular complications with serious consequences on both patient and public health. The Framingham risk score was obtained from a complex study and it estimates the individual risk of each patient to develop a cardiovascular event over the next 10 years depending on certain parameters (age, smoking, total cholesterol, HDL-cholesterol, systolic blood pressure). Our study main aim was to evaluate the cross-associations between the components of the metabolic syndrome, cardiovascular risk, diabetes-related biological parameters and chronic kidney disease in patients hospitalized due to poor metabolic control.
Material and methods: In this cross-sectional study, we enrolled 218 patients with type 2 diabetes, admitted in the Diabetes Clinic of the “Pius Brinzeu” Emergency Hospital Timisoara according to a consecutive-case population-based principle.
Results: We observed that the quality of the glycemic control is impaired in patients with higher age; the body mass index was positively correlated with HbA1c and hypertension accompanies diabetes in more than half of the cases. Moreover, we observed that high levels of LDL cholesterol are significantly correlated with high levels of HbA1c.
Conclusions: There was poor metabolic control in patients with associated complications such as hyperlipidemia, cardiovascular disease or chronic kidney diseases. Also, in most of the cases hypertension was associated with type 2 diabetes mellitus.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. American Diabetes Association Standards of Medical Care in Diabetes - 2017. Diabetes Care 40[Suppl. 1]: S1-S135
2. Haffner SM Lehto S Ronnemaa T Pyorala K Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339: 229-234 1998.
3. NIH/NIDDK. Genetic basis of type 1 and type 2 diabetes obesity and their complications. Advances and emerging opportunities in diabetes research: a Strategic Planning report of the DMICC. 2011 Accessed at: https://www.niddk.nih.gov/about-niddk/strategic-plans-reports/Documents/2011Advances and Emerging Opportunities in Diabetes Research_A Strategic Planning Report of the Diabetes Mellitus Inte/DSP2011_03_GeneticBasis_508.pdf
4. International Diabetes Federation. Epidemiology and Morbidity. In: IDF Diabetes Atlas 4th ed. Brussels Belgium: International Diabetes Federation pp 22-31 2009. Accessed at: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/21-atlas-4th-edition.html
5. Conroy RM Pyorala K Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003 2003.
6. D’Agostino RB Sr Vasan RS Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753 2008.
7. Centers for Disease Control and Prevention. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States 2011. Atlanta GA: U.S. Department of Health and Human Services Centers for Disease Control and Prevention 2011. Accessed at: http://www.diasentry.com/LearningCenter/DiabetesInformation/CDC-DiabtesFacts2011.pdf
8. Ridker PM Buring JE Rifai N Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297: 611-619 2007
9. Gaede P Lund-Andersen H Parving HH Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358: 580-591 2008
10. Ford ES Giles WH Mokdad AH. The distribution of 10-Year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 43: 1791-1796 2004.
11. Brindle P Emberson J Lampe F et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327: 1267 2003.
12. Coleman RL Stevens RJ Retnakaran R Holman RR. Framingham SCORE and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 30: 1292-1293 2007
13. American Diabetes Association Consensus Panel. Guidelines for computer modeling of diabetes and its complications. Diabetes Care 27: 2262-2265 2004.